CCLEAREX.MARKET
Join free
Recce Pharmaceuticals bolsters cash position with A$3.67 million tax refund ahead of Phase 3 milestones
Market IntelligencePublic

Recce Pharmaceuticals bolsters cash position with A$3.67 million tax refund ahead of Phase 3 milestones

Yahoo Finance·June 30, 2026·1 min read
Recce Pharmaceuticals bolsters cash position with A$3.67 million tax refund ahead of Phase 3 milestones
Read full article on Yahoo Finance

Share this article

Follow broker incidents, regulatory actions & market intelligence

Stay ahead with CLEAREX.MARKET

View all intelligence →